Larson Yi

CIK 00017859874 companiesSAN FRANCISCO, CA

SEC Profile

Transactions

Companies

Filings

CIK

0001785987

Recent Transactions

33 trades

Award
Olema Pharmaceuticals, Inc.$OLMA
Stock Option (right to buy)
2025-06-11+24,150→ 24,150 total
Award
Olema Pharmaceuticals, Inc.$OLMA
Stock Option (Right to Buy)
2024-06-14+23,000→ 23,000 total
Disposition to Issuer
RayzeBio, Inc.
Employee Stock Option (right to buy)
2024-02-26−59,399→ 0 total
Disposition to Issuer
RayzeBio, Inc.
Employee Stock Option (right to buy)
2024-02-26−40,848→ 0 total
Disposition to Issuer
RayzeBio, Inc.
Employee Stock Option (right to buy)
2024-02-26−14,332→ 0 total
Award
Olema Pharmaceuticals, Inc.$OLMA
Stock Option (right to buy)
2023-06-16+21,520→ 21,520 total
Award
LianBio$LIANY
Ordinary Shares
2023-03-29+325,901→ 325,901 total
Award
LianBio$LIANY
Stock Option (Right to Buy)
2023-01-20+464,099→ 464,099 total
Award
Olema Pharmaceuticals, Inc.$OLMA
Stock Option (Right to Buy)
2022-06-17+21,520→ 21,520 total
Award
Olema Pharmaceuticals, Inc.$OLMA
Stock Option (Right to Buy)
2022-06-16+21,520→ 21,520 total
Award
LianBio$LIANY
Stock Option (Right to Buy)
2021-12-01+5,996→ 1,202,841 total
Award
LianBio$LIANY
Stock Option (Right to Buy)
2021-10-31+229,538→ 1,196,845 total
Award
Olema Pharmaceuticals, Inc.$OLMA
Stock Option (right to buy)
2021-06-09+21,520→ 21,520 total
Award
Olema Pharmaceuticals, Inc.$OLMA
Stock Option (Right to Buy)
2021-04-05+3,773→ 3,773 total
Award
Olema Pharmaceuticals, Inc.$OLMA
Stock Option (Right to Buy)
2021-04-05+21,520→ 21,520 total
Award
Turning Point Therapeutics, Inc.
Common Stock
2021-02-08+4,617→ 7,321 total
Award
Turning Point Therapeutics, Inc.
Stock Option (right to buy)
2021-02-08+20,775→ 20,775 total
Sale
Turning Point Therapeutics, Inc.
Common Stock
2021-02-02$127.58/sh−1,000→ 16,002 total
Sale
Turning Point Therapeutics, Inc.
Common Stock
2021-02-02$130.58/sh−7,267→ 3,761 total
Sale
Turning Point Therapeutics, Inc.
Common Stock
2021-02-02$129.80/sh−4,574→ 11,028 total
Exercise/Conversion
Turning Point Therapeutics, Inc.
Stock Option (right to buy)
2021-02-02−14,298→ 282,397 total
Sale
Turning Point Therapeutics, Inc.
Common Stock
2021-02-02$131.73/sh−1,057→ 2,704 total
Exercise/Conversion
Turning Point Therapeutics, Inc.
Common Stock
2021-02-02$54.03/sh+14,298→ 17,002 total
Sale
Turning Point Therapeutics, Inc.
Common Stock
2021-02-02$128.41/sh−400→ 15,602 total
Exercise/Conversion
Turning Point Therapeutics, Inc.
Common Stock
2021-02-01$54.03/sh+15,702→ 18,406 total
Sale
Turning Point Therapeutics, Inc.
Common Stock
2021-02-01$123.70/sh−8,576→ 5,047 total
Sale
Turning Point Therapeutics, Inc.
Common Stock
2021-02-01$126.07/sh−200→ 2,704 total
Exercise/Conversion
Turning Point Therapeutics, Inc.
Stock Option (right to buy)
2021-02-01−15,702→ 296,695 total
Sale
Turning Point Therapeutics, Inc.
Common Stock
2021-02-01$122.94/sh−4,783→ 13,623 total
Sale
Turning Point Therapeutics, Inc.
Common Stock
2021-02-01$124.60/sh−2,143→ 2,904 total
Award
Turning Point Therapeutics, Inc.
Stock Option (right to buy)
2020-01-06+33,000→ 33,000 total
Purchase
Turning Point Therapeutics, Inc.
Common Stock
2019-09-10$45.00/sh+2,222→ 2,222 total
Award
Turning Point Therapeutics, Inc.
Stock Option (right to buy)
2019-08-26+312,397→ 312,397 total

Companies

Recent Filings

Address

C/O OLEMA PHARMACEUTICALS, INC. 780 BRANNAN ST

SAN FRANCISCO, CA, 94103

View on SEC.gov